103 related articles for article (PubMed ID: 23608217)
1. [SECOT consensus on thromboembolisms in knee and hip replacement surgery].
Castellet E; Peidró L; Otero R
Rev Esp Cir Ortop Traumatol; 2013; 57(2):150-9. PubMed ID: 23608217
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study.
Howie C; Hughes H; Watts AC
J Bone Joint Surg Br; 2005 Dec; 87(12):1675-80. PubMed ID: 16326885
[TBL] [Abstract][Full Text] [Related]
3. Managing thromboembolic risk in hip and knee arthroplasty: state of the art.
Colwell CW
Orthopedics; 2003 Feb; 26(2 Suppl):s231-6. PubMed ID: 12597231
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
[TBL] [Abstract][Full Text] [Related]
5. [SECOT consensus on painful knee replacement].
Vaquero J; Macule F; Bello S; Chana F; Forriol F
Rev Esp Cir Ortop Traumatol; 2013; 57(5):348-58. PubMed ID: 24071043
[TBL] [Abstract][Full Text] [Related]
6. Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.
Friedman RJ; Sengupta N; Lees M
Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):299-306. PubMed ID: 21671699
[TBL] [Abstract][Full Text] [Related]
7. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry.
Warwick D; Friedman RJ; Agnelli G; Gil-Garay E; Johnson K; FitzGerald G; Turibio FM
J Bone Joint Surg Br; 2007 Jun; 89(6):799-807. PubMed ID: 17613508
[TBL] [Abstract][Full Text] [Related]
8. Extended prophylaxis of venous thromboembolism in major orthopaedic surgery.
Verhaeghe R
Acta Orthop Belg; 2005 Jun; 71(3):255-9. PubMed ID: 16035696
[TBL] [Abstract][Full Text] [Related]
9. Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons.
Anderson FA; Huang W; Friedman RJ; Kwong LM; Lieberman JR; Pellegrini VD;
J Arthroplasty; 2012 May; 27(5):659-66.e5. PubMed ID: 22035977
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism associated with hip and knee replacement over a ten-year period.
Kong KC
J Bone Joint Surg Br; 2006 Feb; 88(2):277. PubMed ID: 16434541
[No Abstract] [Full Text] [Related]
11. Quality improvement program: advancement of hospital venous thromboembolism--free zones.
Merli G
Am J Manag Care; 2011 Feb; 17(1 Suppl):S9-14. PubMed ID: 21517655
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism: management by American Association of Hip and Knee Surgeons.
Markel DC; York S; Liston MJ; Flynn JC; Barnes CL; Davis CM;
J Arthroplasty; 2010 Jan; 25(1):3-9.e1-2. PubMed ID: 19837560
[TBL] [Abstract][Full Text] [Related]
13. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
14. Are the national orthopaedic thromboprophylaxis guidelines appropriate?
Mirkazemi C; Bereznicki LR; Peterson GM
ANZ J Surg; 2012 Dec; 82(12):913-7. PubMed ID: 22989056
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban for the prevention and treatment of venous thromboembolism.
Turpie AG
Fundam Clin Pharmacol; 2012 Feb; 26(1):33-8. PubMed ID: 21851388
[TBL] [Abstract][Full Text] [Related]
16. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
Nielsen JD
Ugeskr Laeger; 2005 May; 167(21):2261-5. PubMed ID: 15962850
[No Abstract] [Full Text] [Related]
17. Prevention of symptomatic pulmonary embolism in patients undergoing total hip and knee arthroplasty: clinical guideline of the American Academy of Orthopaedic Surgeons.
Lachiewicz PF
Instr Course Lect; 2009; 58():795-804. PubMed ID: 19385587
[TBL] [Abstract][Full Text] [Related]
18. Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty: analysis from the RECORD trials.
Cohn DM; Hermanides J; DeVries JH; Kamphuisen PW; Kuhls S; Homering M; Hoekstra JB; Lensing AW; Büller HR
Thromb Haemost; 2012 Feb; 107(2):225-31. PubMed ID: 22187097
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
[TBL] [Abstract][Full Text] [Related]
20. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
